Advertisement
Advertisement
U.S. markets open in 4 hours 19 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Astria Therapeutics, Inc. (ATXS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.98+0.04 (+0.58%)
At close: 4:00PM EDT
6.95 -0.03 (-0.43%)
Pre-Market: 04:34AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close6.94
Open6.89
Bid0.00 x 1100
Ask0.00 x 1200
Day's Range6.88 - 7.13
52 Week Range6.31 - 47.82
Volume19,431
Avg. Volume180,939
Market Cap89.517M
Beta (5Y Monthly)1.70
PE Ratio (TTM)N/A
EPS (TTM)-54.39
Earnings DateNov 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est23.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ATXS

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Astria Therapeutics, Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    28 days agoMorningstar
View more
Advertisement
Advertisement